» Articles » PMID: 35198056

Making Human Pancreatic Islet Organoids: Progresses on the Cell Origins, Biomaterials and Three-dimensional Technologies

Overview
Journal Theranostics
Date 2022 Feb 24
PMID 35198056
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is one of the most socially challenging health concerns. Even though islet transplantation has shown promise for insulin-dependent diabetes, there is still no effective method for curing diabetes due to the severe shortage of transplantable donors. In recent years, organoid technology has attracted lots of attention as organoid can mirror the human organ to the maximum extent thus bridging the gap between cellular- and tissue/organ-level biological models. Concurrently, human pancreatic islet organoids are expected to be a considerable source of islet transplantation. To construct human islet-like organoids, the seeding cells, biomaterials and three-dimensional structure are three key elements. Herein, this review summarizes current progresses about the cell origins, biomaterials and advanced technology being applied to make human islet organoids, and discusses the advantages, shortcomings, and future challenges of them as well. We hope this review can offer a cross-disciplinary perspective to build human islet organoids and provide insights for tissue engineering and regenerative medicine.

Citing Articles

Effects of hydrogel stiffness and viscoelasticity on organoid culture: a comprehensive review.

Lai W, Geliang H, Bin X, Wang W Mol Med. 2025; 31(1):83.

PMID: 40033190 PMC: 11877758. DOI: 10.1186/s10020-025-01131-7.


AG73-GelMA/AlgMA hydrogels provide a stable microenvironment for the generation of pancreatic progenitor organoids.

Wan J, Xu Y, Qi T, Xue X, Li Y, Huang M J Nanobiotechnology. 2025; 23(1):149.

PMID: 40016740 PMC: 11866579. DOI: 10.1186/s12951-025-03266-5.


Mechanical and functional characterisation of a 3D porous biomimetic extracellular matrix to study insulin secretion from pancreatic β-cell lines.

Pliner L, Laneret N, Roudaut M, Mogrovejo-Valdivia A, Vandenhaute E, Maubon N In Vitro Model. 2025; 3(4-6):205-218.

PMID: 39872697 PMC: 11756461. DOI: 10.1007/s44164-024-00078-z.


A Brief History of Cell Culture: From Harrison to Organs-on-a-Chip.

Moro L, Guarnier L, Azevedo M, Fracasso J, Lucio M, Castro M Cells. 2025; 13(24.

PMID: 39768159 PMC: 11674496. DOI: 10.3390/cells13242068.


Hydrogel-Encapsulated Pancreatic Islet Cells as a Promising Strategy for Diabetic Cell Therapy.

Huan Z, Li J, Luo Z, Yu Y, Li L Research (Wash D C). 2024; 7:0403.

PMID: 38966749 PMC: 11221926. DOI: 10.34133/research.0403.


References
1.
Hwang D, Jo Y, Kim M, Yong U, Cho S, Choi Y . A 3D bioprinted hybrid encapsulation system for delivery of human pluripotent stem cell-derived pancreatic islet-like aggregates. Biofabrication. 2021; 14(1). DOI: 10.1088/1758-5090/ac23ac. View

2.
Tao T, Wang Y, Chen W, Li Z, Su W, Guo Y . Engineering human islet organoids from iPSCs using an organ-on-chip platform. Lab Chip. 2019; 19(6):948-958. DOI: 10.1039/c8lc01298a. View

3.
Aloy-Reverte C, Moreno-Amador J, Nacher M, Montanya E, Semino C . Use of RGD-Functionalized Sandwich Cultures to Promote Redifferentiation of Human Pancreatic Beta Cells After In Vitro Expansion. Tissue Eng Part A. 2017; 24(5-6):394-406. DOI: 10.1089/ten.tea.2016.0493. View

4.
Klak M, Kowalska P, Dobrzanski T, Tymicki G, Cywoniuk P, Gomolka M . Bionic Organs: Shear Forces Reduce Pancreatic Islet and Mammalian Cell Viability during the Process of 3D Bioprinting. Micromachines (Basel). 2021; 12(3). PMC: 7999205. DOI: 10.3390/mi12030304. View

5.
Loomans C, Williams Giuliani N, Balak J, Ringnalda F, van Gurp L, Huch M . Expansion of Adult Human Pancreatic Tissue Yields Organoids Harboring Progenitor Cells with Endocrine Differentiation Potential. Stem Cell Reports. 2018; 10(3):712-724. PMC: 5918840. DOI: 10.1016/j.stemcr.2018.02.005. View